Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL11277622 | 0.97 | ALDH1A1 (0.33) | ALDH1A1HPGD | |
| SCHEMBL30969397 | 0.81 | ABCG2 (0.33) | ALDH1A1HPGD | |
| SCHEMBL4130190 | 0.74 | — | — | |
| SCHEMBL9231118 | 0.68 | TSHR (0.43) | ALDH1A1HPGD | |
| SCHEMBL29790875 | 0.67 | PGR (0.33) | ALDH1A1HPGD | |
| SCHEMBL11100915 | 0.67 | CYP3A4 (0.42) | ALDH1A1HPGD | |
| SCHEMBL9298451 | 0.67 | TSHR (0.35) | — | |
| SCHEMBL9504431 | 0.67 | ALDH1A1 (0.35) | ALDH1A1HPGD | |
| SCHEMBL2260662 | 0.67 | MTNR1A (0.49) | — | |
| SCHEMBL13278320 | 0.66 | GABRA1 (0.48) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7112584-B2 | Nonsteroidal antiinflammatory agents | SCHERING AG (DE) | 2006-09-26 | — | — | US | disclosed |
| EP-1572671-A1 | NON-STEROIDAL ANTI-INFLAMMATORY AGENTS | Schering Aktiengesellschaft (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-20040209875-A1 | Nonsteroidal antiinflammatory agents | SCHERIN AKTIENGESELLSCHAFT (DE) | 2004-10-21 | — | — | US | disclosed |
| WO-2004058733-A1 | NON-STEROIDAL ANTI-INFLAMMATORY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-07-15 | — | — | WO | disclosed |
| US-4427666-A | 3,5-Dihalogeno-1,2-methylenedioxybenzene arthropodicide synergizing agents | BAYER AKTIENGESELLSCHAFT (DE) | 1984-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209875-A1 | Nonsteroidal antiinflammatory agents | PTGS1, PTGER1, PTGES | ALDH1A1 96/4885HPGD 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.